Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI

Clinical trial NCT02924727 · COMPLETED

Trial details

NCT number: NCT02924727
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myocardial Infarction

Start date: 2016-12-09
Primary completion: 2021-02-26
Enrollment: 5669

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.